MariMed Inc. (OTC:MRMD) Q4 2025 Earnings Call Transcript

MariMed Inc. (OTC:MRMD) Q4 2025 Earnings Call Transcript March 12, 2026

Operator: Thank you for standing by. At this time, I would like to welcome everyone to the MariMed Fiscal Year and Fourth Quarter 2025 Earnings Call. [Operator Instructions] I would now like to turn the conference over to Andrew Pacheco, General Manager for MariMed in Massachusetts. Sir, the floor is yours.

Unknown Executive: Hello, and good morning, everyone. I’m [ Andrew Pacheco ], General Manager for Massachusetts at MariMed. I’m honored to kick off today’s 2025 fiscal year and fourth quarter earnings call. My team at our New Bedford cultivation and processing facility is responsible for the manufacturing of our great brands that is distributed throughout the state. I’m privileged to see firsthand the expertise collaboration and dedication our employees contribute on a daily basis. They take the company’s mission to improve lives every day very seriously. You’re going to hear during this call about our performance in Massachusetts in 2025 relative to the rest of the market. And I think it’s our team’s commitment to our success, that’s a huge part of what differentiates us and our performance in Massachusetts.

Joining the call today are Jon Levine, our Chief Executive Officer; Ryan Crandall, our Chief Commercial Officer; and Mario Pinho, our Chief Financial Officer. This call will be archived on our Investor Relations website and contains forward-looking statements. Actual events or results may differ materially from these forward-looking statements and are subject to various risks and uncertainties. These risks are discussed in the Risk Factors section of our 10-K and 10-Qs available on our website. Any forward-looking statements reflect management’s expectations as of today and we assume no obligation to update them unless required by law. Additionally, we will refer to certain non-GAAP financial measures, which are reconciled in our earnings release.

I will now turn the call over to Jon for his overview.

Jon Levine: Thank you, Andy. Good morning, everyone, and thank you for joining us. Last night, we reported full year revenue of $160 million for 2025, a 1% increase over 2024. 2025 also marked the sixth consecutive year we generated positive adjusted EBITDA. The cannabis industry continues to evolve rapidly. As we have consistently said, we believe an enduring advantage in this environment will come from only the strongest and most accessible brands. That conviction continues to guide our expand the brand road map, which is built around 3 strategic pillars. First, capturing meaningful market share in our existing markets; second, investing thoughtfully to bring our best-performing brands into new markets; and third, a further strengthening our balance sheet to support long-term growth initiatives.

We made progress across all 3 pillars in 2025. And have continued advancing them into early 2026. With respect to the first pillar, owning a meaningful share in each of our existing markets, our proven wholesale capabilities delivered another strong year as wholesale revenue grew in each of our core markets. Our integrated expertise across cultivation, manufacturing, distribution and marketing. In addition to the quality of our products, has enabled several of our brands to secure leading market positions, notably for the fourth quarter, Betty’s Eddies was the #1 selling edible across the markets where it’s available. In the beverage category, which includes hundreds of ready-to-drink options, our Vibations power to drink mix ranked fourth.

Turning to the second pillar, expanding into new markets, in 2025, we laid the groundwork to bring our brands to Pennsylvania and New York and launched Betty’s Eddies in Maine through a new licensing agreement, expanding through licensing is a clear validation of our brand strength. We’re very confident about the revenue potential for our brands in Pennsylvania, especially with adult sales likely to come in the next year or 2. We’ve watched our product thrives in the neighboring states of Maryland and Delaware. They’re already learning a lot about the Pennsylvania market through the managed services partnership we entered into in 2025. In fact, we helped significantly grow our partners’ revenue during the short period in which we’ve managed their business in Pennsylvania.

We’ve established licensing agreements with the same partner last year and they’ve submitted our products in packaging for state approval. Turning to New York. Construction is underway on the processing kitchen we’re building with our partner. That project is on schedule. In Maine, our new licensing partner began distributing Betty’s Eddies during the fourth quarter of 2025, and we’re tracking with our expectations, achieving positive results with exceptional sell-through at the accounts opened to date. Collectively, Adding these 3 states provide a strategic foothold for MariMed across the Northeast and Mid-Atlantic. Licensing allows us to pursue growth and expand brand distribution in a capital-efficient manner, and we’ll continue to pursue other agreements as part of extend our brand strategy.

This brings me to our third pillar, continuing to strengthen our balance sheet. We have always maintained a strong balance sheet, and we intend to continue fortifying it to support our future growth initiatives. Last week, we successfully completed the restructuring of the convertible stock held by our Series D shareholder. The agreement extended the maturity of the preferred shares further enhancing our financial flexibility to support our growth initiatives. We are pleased to execute the agreement with favorable market terms for the company, along with reductions in operating expense that Mario will discuss our objectives to provide the stability and flexibility required to execute our growth plan. We recognize that implementing all the initiatives I’ve outlined only get us part of the way to our goal of value creation we seek and our investors deserve.

To help us achieve that goal accretive M&A remains an active and imperative avenue for the company. Our Thrive retail stores also play an integral role in our growth plan. First, they serve as premium showcases for our brands. Second, they enable us to cultivate direct-to-consumer relationships through our Thrive loyalty program. Third, and perhaps the most important, retail will continue to generate the majority of our revenue and operating cash flow. In Ohio, we intend to leverage our second retail license with a new Thrive store to be located in the Columbus area. We anticipate it opening this year. In summary, in 2025, we maintained or strengthened our bend leadership across core markets and expanded our geographic reach. We intend to build on our momentum in 2026 while continuing to reinforce our financial foundation.

Our primary growth driver this year will include continued wholesale penetration and full year contributions from Delaware’s expanding adult-use market in our main licensing partnership, and anticipated revenue generated by our new Ohio dispensary. At the same time, we will do everything in our control to move up the time line for distribution of our brands in Pennsylvania and New York. While we remain optimistic about the potential for federal reform and Schedule 3 finally getting over the finish line, our growth strategies do not depend on it. It depends on disciplined capital allocation and the execution capabilities of the strongest team in cannabis and we are fortunate to have both. I want to thank our employees for their dedication, hard work and unwavering commitment.

Their contributions are the foundation of our success. I’ll now turn the call over to Ryan to provide details around our fourth quarter performance.

Ryan Crandall: Thanks, Jon, and good morning, everyone. Let me walk you through our performance at a high level and then across each of our core markets. Our sales, marketing and operations teams delivered another strong year with aggregate wholesale revenue increasing 11% in 2025. Wholesale represents 44% of MariMed’s total revenue, up from 40% in 2024. Our diversified portfolio across flower, vapes, edibles and concentrates continues to resonate with consumers, delivering compelling value and performance across multiple price tiers and in every market we serve. Overall, we increased our penetration into dispensaries in 2025 by 200 basis points, selling our brands into 85% of retail stores in the markets in which we operate.

Turning to retail. We finished the year with momentum, achieving sequential growth of 4% during the fourth quarter compared to a decline of 5% during the same period in 2024. We also increased transactions in our stores by 4% sequentially and 8% year-over-year. Adding Delaware adult-use sales in August was certainly part of our growth story but several initiatives we implemented during the year really started gaining traction toward the end of 2025, helping offset price pressures across our core markets. Those initiatives included centralizing our retail buying, which delivered cross market intelligence and buying power for the company. Second, we improved our assortments and decreased our days on-hand inventories. Working together, these steps elevated our customer experience while also supporting margin expansion.

Third, we unified the Thrive brand across all of our stores, and at the same time, launched a new, more user-friendly website to make online purchasing easier. Fourth, we made it easier to shop inside our stores by expanding our store hours as well as our payment options. And fifth, we focused on generating more revenue through our loyalty program, whose members shop more often and with larger basket sizes than nonmembers. We accomplished that by reactivating dormant membership and by implementing strategies to increase membership. Membership in the program increased 7% sequentially during the fourth quarter and 31% year-over-year. The results of those initiatives give us confidence as we look ahead to this year, especially when combined with new initiatives we’re executing in 2026, which include the following: continuing to focus on accelerating the growth of our loyalty program membership by personalizing its offerings based on member demographics, geographics and buying behaviors.

Next, we launched a Thrive retail app, which will enable us to increase and personalize our communications with Thrive customers at greatly reduced cost. You can download the app thrive dispensaries from the Apple and Android stores today. Third, we’re putting a heavier emphasis on increasing the internalization of MariMed-produced brands in our stores, helping expand the company’s margins. Turning to individual market performance. In Massachusetts, wholesale revenue was flat year-over-year and for the year, mapping the state’s performance according to state sales figures. We ended the year with our products in 83% of the dispensaries in the state, a 4% increase since 2024. In an environment defined by price pressure, the strength and consumer appeal of our brands enabled us to expand our presence across more dispensaries statewide.

Betty’s Eddies and Bubby’s Baked continued to shine, ranking #1 in their respective edible categories. By basins, Nature’s Heritage pre-rolls and InHouse gummies all owned significant share as well with each ranking among the top 10 in their categories. Retail revenue in Massachusetts was flat sequentially and year-over-year. We view that outcome positively given we were able to increase transactions by 5% during the year versus 2024. It’s a recurring theme that sustained pricing pressure in Massachusetts resulted in declines of our AOV. In Maryland, wholesale sales grew 3% in 2025, which was in line with the market’s performance year-over-year. We also maintained nearly 100% penetration across open dispensaries with our products available in 108 of 109 dispensaries.

There’s no resting on our laurels for our Maryland team. Their goal in 2026 is hyper focused on expanding our shelf space in those open accounts. Our brands sustain strong leadership positions in the state with Betty’s Eddies, Bubby’s Baked by basins and InHouse companies all ranked within the top 5 in their respective categories by market share. During the fourth quarter of 2025, retail revenue in Maryland increased 14% sequentially and 18% for the full year compared to 2024, with particular credit due to our Upper Marlboro team for delivering outstanding games. Overall, we increased transactions across our 2 Maryland dispensaries by 35% in 2025 versus 2024. Turning to Illinois, where we began distributing our brands just 2 years ago, wholesale revenue increased 39% in 2025 versus 2024 as we continue building scale.

That compares favorably to the state’s overall cannabis sales, which declined 5% according to [indiscernible]. We expanded distribution into 27 additional dispensaries in Illinois during the year, finishing the year with 82% penetration and reinforcing the competitiveness of our brands in a crowded marketplace. Retail sales in Illinois were flat sequentially and decreased 26% for the full year versus 2024, primarily attributable to the price pressure in that market. In Delaware, we have been very pleased with wholesale performance following the commencement of adult-use sales in August 2025. Wholesale revenue increased 37% sequentially, supported by the expansion of our Milford cultivation facility, which positioned us to meet rising demand.

Our products are available in every Delaware dispensary and according to [indiscernible], our portfolio achieved the #1 overall market share in 2025. Betty’s Eddies, Bubby’s Baked, Vibations and InHouse gummies each ranked #1 in their respective categories. And total sales for both Nature’s Heritage and FSC brands placed us #1 in the flower category. At retail, revenue tracked in line with our expectations following the adult-use transition with sales across our 2 Delaware stores increasing 1.25x following the AU launch. In summary, our business remained resilient in 2025 despite a challenging operating backdrop. We entered 2026 with momentum on our side and well positioned to further strengthen our brand leadership and build on the foundation we have established.

Before turning the call over to Mario, I want to thank all our wholesale and retail employees. They demonstrated the creativity, expertise and commitment necessary to deliver strong results in the challenging environment. I will now turn the call over to Mario to provide the financial update.

Mario Pinho: Thank you, Ryan, and good morning, everyone. For the fourth quarter, total revenue was $41.7 million, bringing full year 2025 revenue to $159.8 million, representing 1.3% sequential growth in the quarter and 7% growth for the full year. Against a broadly flat industry environment, we delivered growth, maintain margin discipline and strengthen liquidity, reflecting continued operational focus across the business. From a mix perspective, fourth quarter retail revenue was $23.4 million, up 3.6% sequentially. Beyond top line growth, retail continues to generate the majority of our operating cash flow and remains the driver of our cash generation profile. During the quarter, we saw a stabilization in store level contribution margins and improved inventory efficiency, reflecting the operational initiatives Ryan outlined earlier.

Wholesale revenue for the quarter was $17.6 million compared to $18 million in the prior quarter. while sequential pricing pressure persisted in certain mature markets, we continue to manage production planning yield optimization and brand positioning to protect contribution margins. Importantly, performance in newer markets with healthier supply-demand dynamics such as Delaware continues to validate our strategy with stronger demand dynamics supporting healthier unit economics. Non-GAAP cost of revenue for the quarter was $25 million, resulting in gross profit of $16.5 million. Non-GAAP gross margin declined modestly to 40%. Operational efficiencies across cultivation and manufacturing helped offset pressure in certain mature markets, allowing us to maintain margin stability.

Turning to operating expenses. Total operating expenses were $56.9 million for the year, representing only a 0.7% increase compared to 2024. This reflects continued discipline across SG&A even as we invested selectively in brand expansion and new market infrastructure. This expense discipline demonstrated the scalability of our operating model and our ability to generate operating leverage as revenue grows. Operating income for the quarter was $2.4 million, down $667,000 sequentially. For the full year, operating income was $8.8 million compared to $11.4 million in 2024. The decline primarily reflects lower gross profit in certain mature markets as well as a negative contribution from our Missouri operations prior to our exit in October. Excluding Missouri, the year-over-year decline would have been meaningfully smaller, reflecting disciplined cost control across the organization.

On an adjusted basis, operating margin declined less than 1 percentage point year-over-year, demonstrating the effectiveness of our cost discipline. From a full year cash earnings perspective, non-GAAP EBITDA for the 2025 was $16.9 million, representing a margin of 10.5%. This margin reflects a disciplined balance between protecting profitability in a pricing compressed environment and continuing to invest in long-term value drivers such as brand expansion and market positioning. For the full year, non-GAAP EBITDA declined 12.8% year-over-year, primarily reflecting lower gross profit and the impact of Missouri operations prior to our exit in October. These factors were partially offset by disciplined cost control and operational efficiencies across the business.

Turning to capital discipline and liquidity. Cash flow from operations remained positive during the quarter and for the year, supported by disciplined working capital management — we exited noncore operations with Missouri maintain measured capital expenditures and prioritize liquidity preservation in a constrained capital environment. We ended the year with $8.9 million in cash and cash equivalents, up from $7.3 million at the end of 2024. In addition, as Jon mentioned, we recently completed the restructuring of our Series B preferred shares, extending maturities and enhancing financial flexibility. Importantly, we have no material debt maturities in the near term, positioning us to execute our growth strategy without near-term capital pressure.

Looking ahead, our financial focus remains centered on 3 objectives: driving margin expansion through mix optimization and cost management, prioritizing capital deployment into the highest return opportunities and finally, strengthening liquidity and financial flexibility. We believe our disciplined approach to liquidity will position us to create long-term shareholder value while navigating near-term sector volatility. With that, I’ll turn the call over to Jon.

Jon Levine: Thank you, Mario. In summary, I’m proud of what MariMed accomplished in 2025, and I’m excited about our prospects for 2026 and beyond. Our company performed well in a challenging environment. Looking ahead, we have a strong leadership team, strong business fundamentals, outstanding brand and no material debt maturing for the next several years. Together with the strategic initiatives we have underway, we are confident in MariMed’s tremendous upside over the long term. Operator, you can now open the line for questions.

Q&A Session

Operator: [Operator Instructions] Your first question comes from Pablo Zuanic with Zuanic & Associates.

Pablo Zuanic: Look, special thanks to Ryan for all the color that he gave at the state level. I just want to follow up on a couple of points there. I think you said Illinois retail revenue flat sequentially, but down 26% for the year. My question is more about we’ve seen the rise in the number of stores in Illinois. I think we’re already getting close to the gap. So the effect from the new stores should begin to subside. I mean, correct me if I’m wrong on that because, I mean, the fact that you — after a big growth for the year, that Illinois store revenues are stabilizing, that’s a good sign? Or do you still expect deflation in 2026 and still expect more revenue per store erosion in 2026? I’m speaking specifically about Illinois.

Unknown Executive: Thank you for the question. I think we still see some price compression happening in Illinois. But I do tend to agree with you overall that we do believe the market seems to be stabilizing, at least our stores seem to be stabilizing. But price compression is still real in that market, and it is forecasted to compress more in ’26.

Pablo Zuanic: All right. And if you don’t mind, I think you gave the detail for revenues for Illinois in terms of retail, but can you say in total, what happened with Illinois in the fourth quarter, accounting retail and wholesale and then Massachusetts also retail and wholesale? And again, I don’t know if you provided that or not in the prepared remarks, I’m not sure.

Mario Pinho: Pablo, it’s Mario. Specific to Illinois?

Pablo Zuanic: Yes. I’m just trying — I know as you said for the year, Retail, Illinois was down 26%, but wholesale was up, right? So I’m just trying to — and again, we can follow up offline. But just trying to understand the total revenue for Illinois will happen in the fourth quarter and the full year and the same thing for Massachusetts. Obviously, Massachusetts more stable in total compared to Illinois, but just trying to gauge that.

Mario Pinho: Yes, we can definitely follow up in detail offline, but sequentially in Illinois, we were down. and primarily driven by the retail side of our product revenue.

Aaron Grey: Right. Okay. And then just moving on to Delaware. Can you comment on your expectations for how fast the number of stores can grow in Delaware, I mean, obviously, that will create great opportunities on the wholesale side but may lead to some revenue erosion at the store level. But what’s the outlook there on timing in — from what you know for the market in Delaware?

Unknown Executive: Yes. Pablo, thank you. We are closely working with new stores prior to opening. I think it has been good. We have seen some new stores getting close to coming online. But at this point, it has been a relatively slow rollout of new stores. We are increasing our sell-in to stores across the state and as I mentioned, our brands are leading positions across the state in almost every category, and we have a plan to get there in every category. So very bullish as the new stores come online that we’re going to be able to supply those stores and be partners with them out of the gate and make our brands really kind of first movers in every store in that market.

Pablo Zuanic: Right. And then just a follow-up here. These are more modeling questions, but in Ohio, Columbus store, when do you expect exactly that to open roughly. And then in the case of the Upper Marlboro store, trade growth sequentially, is that base — again, is that sustainable that growth pace or was that one-off related to the fourth quarter?

Jon Levine: Pablo, this is Jon to speak to you again today. First of all, [indiscernible] it, but we do know that it will be in this year, and we’re going to expect as we can to get the building up and running. [indiscernible]. That’s a big positive that we are seeing is that [indiscernible] is very willing to work quickly. As far as the [indiscernible], that business has been very strong there for a very small store. It is just a pleasure to watch that continue to grow. And I do believe that it will continue to see additional growth and can handle it. I just think part of it is that the — that it is so hard to find real estate in Upper Marlboro county that we’re getting an advantage even though we’re a small store, not easily seen, but we’re seeing positives that people are hearing about it and coming in droves.

Pablo Zuanic: And the last one, maybe bigger picture. I know that you are following an asset-light expansion model. I guess, in my opinion, those are my words, of course, with the licensing deals in New York and Maine. But what about acquisitions in terms of entering other states and buying hard assets? Is that part of the strategy or not for now, just protect the balance sheet and keep it asset light?

Jon Levine: No, Pablo, as I said, the big growth opportunities is to still be active in the M&A and we’re out there talking to quite a few different groups. There’s a lot of fire sales going on, but they have to be for the right price. We don’t want to do something that will be not beneficial for the company or make our balance sheet worse. So we are constantly negotiating but they also have to have some upside. We don’t want people that are not capable of running a place that we could go in and turn it around, but we would also want to make sure that we’re not buying something that’s being the price compression and competition take away from their ability to survive in that market. Massachusetts where there’s the biggest over slot of licenses is you’re seeing a lot of people going out of business.

And there’s the opportunity coming up with the expansion in Massachusetts that we hear that they are going to increase the number of licenses. So we are actively looking at trying to gain some more market share.

Pablo Zuanic: I had one more, if I may, my apologies, if there’s anyone else in the queue here. In the case of the licensing agreement in New York and the MSA in Pennsylvania, is there a path to take control of those assets someday or nothing on paper right now?

Jon Levine: There is presently nothing on paper. We’re also — I mean, going into these markets on the licensing ability to learn the markets and to see how those markets react not just to our brands, but just to see what there is in the market in terms of growth potential. And we will look at negotiating with our partners if there is the opportunity to either buy them or join them in some other way than just the licensing agreement.

Operator: Your next question comes from Joe Gomes with NOBLE Capital.

Joseph Gomes: I wanted to follow up on the Pennsylvania and New York. Jon, doesn’t — from your comments as to what you were looking ahead for ’26 to fuel growth doesn’t sound like either one of those will be big contributors in ’26. I just wanted to make sure I am reading that properly.

Jon Levine: You’re reading it properly in the way that we’ve made the statements. We are presently in construction in New York. We’re hopeful that we can get that operation up and running before the end of the year. and build the inventory to start revenue either late the year or early in ’27. And Pennsylvania is just basically, we have to get the approval of our brands and everything by the state, and then we can go into the manufacturing and building up the inventory in that state also, but it’s more of the timing that is out of our control. So we are just not sitting here saying that we’re going to have that done. So we’re going to be a little bit conservative on that approach. But we’re very excited about the opportunity in Pennsylvania. And we’re still building up our brands in the state of Maine with our licensing up there also. So the licensing is working positive up there.

Joseph Gomes: Okay. And then given the fact that your penetration already is at about 85% in the core market, how much more is available, do you think, from that to help drive growth in ’26 and getting additional penetration?

Jon Levine: Yes, Joe, thank you for the question. We talk about that often. And it’s a tremendous opportunity for us having that type of penetration in these core markets. And so from a product and brand standpoint the ability to go wider and deeper with these customers as we’re already a trusted vendor of theirs. I think that’s our opportunity. We do believe that, that’s a tremendous opportunity on the wholesale side. And I think as you see the trajectory of going from 40% of our revenue to 44% and still increasing the revenue year-over-year, that increased penetration can only help us if we have more products to bear for buyers.

Joseph Gomes: Okay. And just one more for me, and I’ll get back in queue. So great job on the refi. Just what will that increase in interest cost or interest expense for on an annual basis?

Jon Levine: That number is approximately $800,000.

Operator: This concludes the question-and-answer portion of the call and today’s call. Thank you so much for attending. You may now disconnect, and have a wonderful rest of your day.